160 related articles for article (PubMed ID: 10563640)
41. Genetic causes of Parkinson's disease: UCHL-1.
Healy DG; Abou-Sleiman PM; Wood NW
Cell Tissue Res; 2004 Oct; 318(1):189-94. PubMed ID: 15221445
[TBL] [Abstract][Full Text] [Related]
42. Intron-exon structure of ubiquitin c-terminal hydrolase-L1.
Leroy E; Boyer R; Polymeropoulos MH
DNA Res; 1998 Dec; 5(6):397-400. PubMed ID: 10048490
[No Abstract] [Full Text] [Related]
43. Effects of UCH-L1 on alpha-synuclein over-expression mouse model of Parkinson's disease.
Yasuda T; Nihira T; Ren YR; Cao XQ; Wada K; Setsuie R; Kabuta T; Wada K; Hattori N; Mizuno Y; Mochizuki H
J Neurochem; 2009 Feb; 108(4):932-44. PubMed ID: 19141079
[TBL] [Abstract][Full Text] [Related]
44. Characterization of the testis in congenitally ubiquitin carboxy-terminal hydrolase-1 (Uch-L1) defective (gad) mice.
Kwon J; Kikuchi T; Setsuie R; Ishii Y; Kyuwa S; Yoshikawa Y
Exp Anim; 2003 Jan; 52(1):1-9. PubMed ID: 12638230
[TBL] [Abstract][Full Text] [Related]
45. CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders.
Mondello S; Constantinescu R; Zetterberg H; Andreasson U; Holmberg B; Jeromin A
Parkinsonism Relat Disord; 2014 Apr; 20(4):382-7. PubMed ID: 24507721
[TBL] [Abstract][Full Text] [Related]
46. Association between the ubiquitin carboxyl-terminal esterase L1 gene (UCHL1) S18Y variant and Parkinson's Disease: a HuGE review and meta-analysis.
Ragland M; Hutter C; Zabetian C; Edwards K
Am J Epidemiol; 2009 Dec; 170(11):1344-57. PubMed ID: 19864305
[TBL] [Abstract][Full Text] [Related]
47. [The ubiquitin-proteasome system and neurodegeneration].
Wada K; Osaka H; Aoki S; Wang YL
Rinsho Shinkeigaku; 2001 Dec; 41(12):1072-4. PubMed ID: 12235799
[TBL] [Abstract][Full Text] [Related]
48. Loss of Uch-L1 and Uch-L3 leads to neurodegeneration, posterior paralysis and dysphagia.
Kurihara LJ; Kikuchi T; Wada K; Tilghman SM
Hum Mol Genet; 2001 Sep; 10(18):1963-70. PubMed ID: 11555633
[TBL] [Abstract][Full Text] [Related]
49. Cyclopentenone prostaglandin-induced unfolding and aggregation of the Parkinson disease-associated UCH-L1.
Koharudin LM; Liu H; Di Maio R; Kodali RB; Graham SH; Gronenborn AM
Proc Natl Acad Sci U S A; 2010 Apr; 107(15):6835-40. PubMed ID: 20231490
[TBL] [Abstract][Full Text] [Related]
50. [Molecular pathogenesis of familial Parkinson's disease].
Kitada T; Mizuno Y
Nihon Rinsho; 2000 Oct; 58(10):2016-21. PubMed ID: 11068440
[TBL] [Abstract][Full Text] [Related]
51. The ubiquitin pathway in Parkinson's disease.
Leroy E; Boyer R; Auburger G; Leube B; Ulm G; Mezey E; Harta G; Brownstein MJ; Jonnalagada S; Chernova T; Dehejia A; Lavedan C; Gasser T; Steinbach PJ; Wilkinson KD; Polymeropoulos MH
Nature; 1998 Oct; 395(6701):451-2. PubMed ID: 9774100
[No Abstract] [Full Text] [Related]
52. Association between a polymorphism of ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) gene and sporadic Parkinson's disease.
Zhang J; Hattori N; Leroy E; Morris HR; Kubo S; Kobayashi T; Wood NW; Polymeropoulos MH; Mizuno Y
Parkinsonism Relat Disord; 2000 Oct; 6(4):195-197. PubMed ID: 10900392
[TBL] [Abstract][Full Text] [Related]
53. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice.
Saigoh K; Wang YL; Suh JG; Yamanishi T; Sakai Y; Kiyosawa H; Harada T; Ichihara N; Wakana S; Kikuchi T; Wada K
Nat Genet; 1999 Sep; 23(1):47-51. PubMed ID: 10471497
[TBL] [Abstract][Full Text] [Related]
54. Analysis of the UCHL1 genetic variant in Parkinson's disease among Chinese.
Tan EK; Lu CS; Peng R; Teo YY; Wu-Chou YH; Chen RS; Weng YH; Chen CM; Fung HC; Tan LC; Zhang ZJ; An XK; Lee-Chen GJ; Lee MC; Fook-Chong S; Burgunder JM; Wu RM; Wu YR
Neurobiol Aging; 2010 Dec; 31(12):2194-6. PubMed ID: 19329225
[TBL] [Abstract][Full Text] [Related]
55. The role of ubiquitin C-terminal hydrolase L1 in neurodegenerative disorders.
Gong B; Leznik E
Drug News Perspect; 2007; 20(6):365-70. PubMed ID: 17925890
[TBL] [Abstract][Full Text] [Related]
56. UCHL-1 is not a Parkinson's disease susceptibility gene.
Healy DG; Abou-Sleiman PM; Casas JP; Ahmadi KR; Lynch T; Gandhi S; Muqit MM; Foltynie T; Barker R; Bhatia KP; Quinn NP; Lees AJ; Gibson JM; Holton JL; Revesz T; Goldstein DB; Wood NW
Ann Neurol; 2006 Apr; 59(4):627-33. PubMed ID: 16450370
[TBL] [Abstract][Full Text] [Related]
57. Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease.
McNaught KS; Olanow CW
Ann Neurol; 2003; 53 Suppl 3():S73-84; discussion S84-6. PubMed ID: 12666100
[TBL] [Abstract][Full Text] [Related]
58. The genetics of Parkinson's disease.
de Silva HR; Khan NL; Wood NW
Curr Opin Genet Dev; 2000 Jun; 10(3):292-8. PubMed ID: 10826990
[TBL] [Abstract][Full Text] [Related]
59. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
Corti O; Brice A
Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
[TBL] [Abstract][Full Text] [Related]
60. The role of common genetic risk variants in Parkinson disease.
Tan EK
Clin Genet; 2007 Nov; 72(5):387-93. PubMed ID: 17868389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
